Welcome to our dedicated page for Edgewell Pers Care Co SEC filings (Ticker: EPC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Edgewell Personal Care Company filings document the financial reporting, governance and capital-structure disclosures of a Missouri-incorporated personal-care company whose common stock trades on the New York Stock Exchange under EPC. Current Reports on Form 8-K furnish quarterly and fiscal-year operating results, non-GAAP earnings materials and Regulation FD updates.
The filing record also covers completed asset-disposition disclosures for the sale of the Feminine Care segment and transition services arrangements related to that transaction. Proxy materials document annual meeting matters, director and executive compensation governance, shareholder voting items and approval of the amended and restated 2018 Stock Incentive Plan.
Rubric Capital Management and David Rosen reported joint beneficial ownership of 4,000,000 shares of Edgewell Personal Care Company Common Stock, representing 8.56% of the class. The ownership percentage is calculated using 46,716,605 shares outstanding as of January 31, 2026 per the issuer's Form 10-Q. The Schedule 13G lists shared voting and shared dispositive power over the reported shares and identifies Rubric Capital Master Fund LP as having the right to receive dividends or sale proceeds on more than 5% of the class.
Edgewell Personal Care — Brandes Investment Partners filed an amended Schedule 13G reporting beneficial ownership of 6,723,479 common shares (14.39%) as of 03/31/2026. The filing shows shared voting power of 4,719,974 and shared dispositive power of 6,723,479.
The amendment is signed on 05/08/2026 by Glenn Carlson, Executive Director, and discloses the institutional holder's position in the issuer's common stock pursuant to Schedule 13G/A requirements.
Edgewell Personal Care Company reported Q2 fiscal 2026 net sales of $519.5 million, up 0.6% year over year, but profitability weakened. Net income from continuing operations fell to $4.0 million, or $0.09 diluted EPS, and total net loss was $10.6 million including discontinued operations.
The company closed the sale of its Feminine Care segment to Essity for approximately $340 million on a cash‑free, debt‑free basis, recording a $37.4 million goodwill impairment and a $2.2 million loss on assets held for sale. Feminine Care is now reported as discontinued operations.
Restructuring to streamline manufacturing and Wet Shave operations weighed on results, with $32.1 million restructuring charges in the first half and an expected $90 million of related charges in fiscal 2026. Adjusted diluted EPS from continuing operations was $0.60 for Q2 and $0.44 for the first six months, both below the prior-year periods despite slightly higher sales.
Edgewell Personal Care reported second-quarter fiscal 2026 net sales of $519.5 million, up 0.6%, while organic net sales fell 2.4%. GAAP diluted EPS from continuing operations dropped to $0.09 from $0.43, and adjusted EPS declined to $0.60 from $0.69.
Adjusted EBITDA from continuing operations was $73.8 million versus $84.7 million a year earlier, as gross margin and segment profits contracted despite productivity savings. The company reaffirmed its full-year outlook for organic net sales, adjusted EPS of $1.70–$2.10 and adjusted EBITDA of $245–$265 million, but lowered GAAP EPS guidance to flat–$0.40 due to higher restructuring and legal costs. Edgewell ended the quarter with $299.7 million in cash, a $418.8 million undrawn revolver and declared a $0.15 quarterly dividend.
Edgewell Personal Care Co reports a 13G filing: Vanguard Capital Management beneficially owns 2,378,243 shares of Common Stock, representing 5.09% of the class.
The filing states Vanguard Capital Management has sole voting power for 340,848 shares and sole dispositive power for 2,378,243 shares. Ownership is reported on behalf of Vanguard funds and managed accounts; the filing is signed 04/29/2026.
Edgewell Personal Care Co reports an institutional Schedule 13G filing showing Vanguard Portfolio Management beneficially owned 6.56% of Common Stock, equal to 3,065,063 shares as of 03/31/2026.
Vanguard Portfolio Management disclosed sole dispositive power over 3,065,063 shares and sole voting power for 136,694 shares. The filing is signed by Ashley Grim on 04/29/2026.
Edgewell Personal Care Co: an amendment to a Schedule 13G/A from The Vanguard Group reports zero beneficial ownership of Edgewell common stock following an internal realignment. The filing states that, effective January 12, 2026, certain Vanguard subsidiaries and business divisions will report holdings separately and that The Vanguard Group, Inc. no longer is deemed to beneficially own securities held by those affiliates. The filing is signed on 03/26/2026 and lists 0 shares and 0% ownership for The Vanguard Group in Edgewell common stock.
Brandes Investment Partners, L.P. reports beneficial ownership of 6,121,589 common shares of Edgewell Personal Care Co., representing 13.1% of the class as of the reported date.
Brandes has shared voting power over 4,112,649 shares and shared dispositive power over all 6,121,589 shares, with no sole voting or dispositive authority. The firm files as an investment adviser and certifies the shares were acquired and are held in the ordinary course of business, not to change or influence control of Edgewell.
Edgewell Personal Care reported first‑quarter fiscal 2026 net sales of $422.8 million, up 1.9% year over year, but swung to a much larger loss. From continuing operations, the company posted a net loss of $29.2 million, with total net loss of $65.7 million including discontinued operations.
Results were hit by $18.1 million of restructuring charges and $5.8 million of related costs, plus a $37.4 million goodwill impairment and $3.8 million loss on assets held for sale tied to the divestiture of the Feminine Care segment. Gross profit fell to $161.0 million and gross margin declined as inflation, tariffs and lower volume outweighed productivity savings.
Wet Shave sales slipped to $291.3 million and segment profit declined to $42.2 million, while Sun and Skin Care sales rose 9.0% to $131.5 million but remained slightly unprofitable. Operating cash flow was negative $125.9 million, and total borrowings reached $1.56 billion, including $277.0 million drawn on the U.S. revolver. The sale of Feminine Care to Essity for about $340 million closed after quarter‑end and is earmarked primarily for debt reduction and reinvestment.
Edgewell Personal Care Co. director Sit Swan reported an equity grant. On February 5, 2026, the director was awarded 7,817 restricted stock equivalents at a price of $0 per unit, held directly.
These restricted stock equivalents convert into shares of Edgewell common stock on the day before the next annual shareholder meeting, unless the director elects to defer conversion until service on the Board ends.